About 1,670 results
Open links in new tab
  1. CoreValve™ and Evolut™ TAVR Systems - Medtronic

    The CoreValve system is a Transcatheter Aortic Valve Replacement (TAVR) device used in a procedure that is less invasive than open-heart surgery. It provides an important treatment option for patients …

  2. CoreValve System Transcatheter Aortic Valve Delivery Catheter System Compression Loading System CAUTION: Implantation of the Medtronic CoreValve™ system should be

  3. Transcatheter Aortic Valve Implantation (TAVI) | Medtronic

    We would like to show you a description here but the site won’t allow us.

  4. CoreValve TAVR - HAVHRT

    CoreValve is a Transcatheter Aortic Valve Replacement (TAVR) procedure is a less invasive treatment option than open heart valve surgery. With CoreValve TAVR, a small incision is made and a thin, …

  5. Transcatheter Aortic Valve Replacement (TAVR) | Medtronic

    Transcatheter aortic valve replacement (TAVR) is a treatment option for severe aortic stenosis. Explore the Medtronic TAVR procedure, patient stories, benefits and risks, and search for a TAVR physician …

  6. CoreValve: Innovative Treatment For Heart Valve Disease - Patient9.com

    The CoreValve device is a self-expanding valve that is delivered to the heart through a small incision in the leg or chest. The device is positioned inside the native valve and expands to replace the …

  7. Evolution in transcatheter aortic valve replacement: the CoreValv

    The CoreValve, as opposed to the Edwards valve (Edwards Lifesciences, CA, USA), is a self-expanding device, which can be deployed in a ‘step-wise’ fashion, theoretically permitting accurate device …

  8. Valve-in-valve TAVR with Medtronic’s CoreValve devices still safe and ...

    Jan 22, 2024 · All patients were treated with a CoreValve TAVR valve from the trial’s sponsor, Medtronic. Overall, the group reported, the five-year composite outcome of all-cause mortality or …

  9. Five-Year Clinical and Quality of Life Outcomes From the CoreValve US ...

    Jun 7, 2021 · The CoreValve US Extreme Risk Pivotal Trial was a prospective, nonrandomized, single-arm clinical trial of TAVR at 41 sites in the United States. The primary outcome was all-cause …

  10. The CoreValve transcatheter aortic valve has been approved by fDa for specific patient populations only. refer to the instructions for Use for a full list of warnings, precautions, indications,...